About the ADPP
The Alzheimer’s Disease Prevention Program focuses on research, education and treatment aimed at preventing Alzheimer’s disease and late-life cognitive decline.
Alzheimer’s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills. Current estimates put the number of people with Alzheimer’s disease at more than 5 million in the U.S., and with the “graying’’ of the population, more Americans will be at risk for Alzheimer’s disease than ever before.
The Wake Forest School of Medicine Alzheimer’s Disease Prevention Program was created to:
- Establish a comprehensive research infrastructure to identify the causes of Alzheimer’s disease and potential prevention or treatment of the disease.
- Provide specialized resources to accelerate research into the role of metabolic and vascular factors in the causes of Alzheimer’s disease and the development of novel interventions.
- Improve the recruitment of African-American adults in research and educational programs to better understand and treat the causes underlying the increased risk of Alzheimer’s disease and dementia in the African-American population.
- Provide education regarding Alzheimer’s disease and related dementias to health professionals, researchers, patients and their families, and the community at large.